Balaji Amines fell 2.61% to Rs 2,005, extending its losing run for the fifth consecutive trading session.

Balaji Amines hits 52-week low; slips 12% in five days

KR Choksey is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 3790 in its research report dated February 13, 2023.

Buy Balaji Amines; target of Rs 3790: KR Choksey

Balaji Amines share price: The stock traded lower than 5-day, 20-, 50-, 100- and 200-day moving averages. The counter’s 14-day relative strength index (RSI) came at 23.95. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company’s stock has a price-to-equi…

Balaji Amines shares slip 6% after Q3 results; here’s what tech charts hint

The company said the fall in operating margin was primarily on account of de-growth in pharma and API sector

Balaji Amines slips 6%, hits 52-week low on disappointing Q3 results

The fall in operating margin was primarily on account of degrowth in pharma and active pharmaceutical ingredients sector

Balaji Amines declines on weak operational show, but management stays bullish

Balaji Amines Consolidated December 2022 Net Sales at Rs 585.95 crore, up 3.73% Y-o-Y

Balaji Amines Standalone December 2022 Net Sales at Rs 413.17 crore, down 12.52% Y-o-Y

Adani Transmission, Tata Steel, Varun Beverages, Easy Trip Planners, Tejas Networks, Balaji Amines, LIC Housing Finance and Muthoot Finance will announce their December quarter results later today.

Sona BLW Precision, Concor to go ex-dividend; Adani Transmission, Tata Steel Q3 results today

Balaji Amines consolidated net profit rises 16.08% in the September 2022 quarter

Balaji Amines’ consolidated net profit rose 16.08% to Rs 92.58 crore on a 19.37% increase in revenue from operations to Rs 627.55 crore in Q2 FY23 over Q2 FY22.

Balaji Amines Q2 PAT up 16% YoY to Rs 92 cr

Balaji Amines Consolidated September 2022 Net Sales at Rs 627.56 crore, up 19.37% Y-o-Y

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Balaji Amines Limited is a company, which is engaged in the manufacturing of Aliphatic Amines, their derivatives and specialty chemicals. The Company is running a five star hotel, Balaji Sarovar Premiere.